Clinical study on the treatment of qi stagnation and phlegm obstruction dyslipidemia with Jieyu Qutan Huazhuo prescriptio
- Conditions
- hypertriglyceridemia
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) Aged between 18 and 80;
(2) Meet the diagnostic criteria of hypertriglyceridemia;
(3) Meet the diagnostic criteria of qi stagnation and phlegm obstruction syndrome;
(4) Those who are using other lipid-lowering drugs or therapies (including physical therapy) should stop taking the drugs or stop the therapy and still meet the above standards after 2 weeks of elution;
(5) Voluntarily join the study and sign the informed consent.
(1) Secondary hypertriglyceridemia caused by hypothyroidism, nephrotic syndrome, diabetes and other diseases;
(2) Have suffered from acute cardiovascular and cerebrovascular events or severe trauma within 1 year;
(3) Patients who need to take drugs with definite influence on triglyceride level for a long time after previous PCI or other major surgery;
(4) Patients suffering from systemic serious diseases of the heart, brain, liver, kidney and immune system, or mental patients;
(5) The patient is using drugs that affect lipid metabolism, such as glucocorticoids, thyroid hormones, and moderate potency diuretics
(6) The patient or his/her spouse is in the stage of pregnancy, pregnancy or lactation;
(7) People who may be allergic to the drug in this test;
(8) Other circumstances that may affect the efficacy and safety of the test drug.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Triglyceride levels;
- Secondary Outcome Measures
Name Time Method TCM syndrome score;